Table 1.
Patient characteristics.
ALK n (%) | EGFR n (%) | Fisher's exact test p-value | |
---|---|---|---|
Sex | |||
F | 22 (73%) | 71 (73%) | 1.000 |
M | 8 (27%) | 26 (27%) | |
Smoking history | |||
No | 23 (77%) | 70 (72%) | 0.814 |
Yes | 7 (23%) | 27 (28%) | |
Stage I | 3 (10%) | 23 (24%) | |
Stage II | 1 (3%) | 3 (3%) | Stage I vs Stage |
Stage III | 8 (27%) | 10 (10%) | II + III + IV: 0.125 |
Stage IV | 18 (60%) | 61 (63%) | |
ALK | EGFR | Wilcoxon rank-sum test | |
n (%) | n (%) | p-value | |
| |||
Age, median (range) | 49.5 (36.0, 76.2) | 63.4 (32.6, 89.9) | <0.001 |